News
Published over 16 years ago. See the latest and most current information on News.
GEA Lyophil, part of GEA Pharma Systems, has won a milestone order from the Zheiiang Hisun Pharmaceutical Co. Ltd in Taizhou Zheiiang, China for the supply of pharmaceutical freeze dryers with automatic load and unload systems (ALUS). The order is a major breakthrough in the region allowing Hisun to expand its operations into formulated pharmaceutical products for injection focus in oncology and infective diseases.
GEA Lyophil GmbH will supply seven freeze drying systems and five ALUS systems with a total value in excess of 15 million Euro. The equipment will be used at the new facilities in the Fuyang pharmaceutical valley and will allow Hisun to focus on the production of anti-tumour, anti-infective, general biologics and anti-TB product for both the domestic and export markets. Hisun is planning to invest over 100 million euro in the Fuyang facility making it one of the biggest pharmaceutical production sites in China.
The Chinese pharmaceutical industry is investing heavily in top quality production technology both for domestic and export pharmaceuticals. This recent order for GEA Lyophil is a clear illustration of this trend.
ILM Guide 2026/27